New program aims to ease mental and physical side effects of immunotherapy

NCT ID NCT05715255

Ongoing Symptom relief Sponsor: University of Arizona Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests a personalized self-management program to help cancer survivors on immune checkpoint inhibitors better handle side effects and reduce anxiety or depression. About 400 adults with breast, colon, lung, skin, or rectal cancer who recently started immunotherapy will take part. Participants will report symptoms weekly and receive guidance to manage them, with the goal of improving quality of life and reducing treatment disruptions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colon carcinoma colonic neoplasm lung cancer lung neoplasm neoplasm rectal cancer rectal neoplasm skin cancer skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COLON CANCER LUNG CANCER RECTUM CANCER SKIN CANCER

Contacts and locations

Locations

University of Arizona Cancer Center

Tucson, Arizona, 85724, United States
University of Michigan

Ann Arbor, Michigan, 48109, United States
Valleywise Health Medical Center

Phoenix, Arizona, 85008, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.